Among 371 randomized patients, 64.7% of sparsentan-treated patients achieved partial proteinuria remission -- defined by a urine protein-to-creatinine ratio (UPCR) of ≤1.5 g/g and >40% reduction ...

This is generally defined as a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g. 1 Vanrafia™ is a once-daily, non-steroidal, oral therapy that can be added onto supportive care, including a ...